OXiGENE to boost cash position with VaxGen acquisition
This article was originally published in Scrip
Executive Summary
OXiGENE is to acquire fellow US biotechnology company VaxGen in a stock based deal that will see VaxGen becoming a wholly owned subsidiary of OXiGENE.